Plasma Aβ1–40 and Aβ1–42 and the risk of dementia: a prospective case-cohort study
- 1 August 2006
- journal article
- research article
- Published by Elsevier in The Lancet Neurology
- Vol. 5 (8) , 655-660
- https://doi.org/10.1016/s1474-4422(06)70501-4
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- P3-011 Analysis of plasma Aβ42 ASA premorbid biomarker for late onset Alzheimer's diseaseNeurobiology of Aging, 2004
- Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesionsAnnals of Neurology, 2004
- RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brainNature Medicine, 2003
- Brain to Plasma Amyloid-β Efflux: a Measure of Brain Amyloid Burden in a Mouse Model of Alzheimer's DiseaseScience, 2002
- Amyloid β Protein in Plasma as a Diagnostic Marker for Alzheimer’s DiseaseNeurobiology of Aging, 1998
- Fate of Cerebrospinal Fluid‐Borne Amyloid β‐Peptide: Rapid Clearance into Blood and Appreciable Accumulation by Cerebral ArteriesJournal of Neurochemistry, 1996
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Platelets Are the Primary Source of Amyloid β-Peptide in Human BloodBiochemical and Biophysical Research Communications, 1995
- Normal and Abnormal Biology of the beta-Amyloid Precursor ProteinAnnual Review of Neuroscience, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984